PlainRecalls
FDA Drug Moderate Class II Terminated

Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25).

Reported: August 9, 2017 Initiated: June 15, 2017 #D-1048-2017

Product Description

Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25).

Reason for Recall

Lack of Sterility Assurance

Details

Recalling Firm
Hospira a Pfizer Company
Units Affected
15,034,600 10 mL multiple dose use vials
Distribution
U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore
Location
Rocky Mount, NC

Frequently Asked Questions

What product was recalled?
Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25).. Recalled by Hospira a Pfizer Company. Units affected: 15,034,600 10 mL multiple dose use vials.
Why was this product recalled?
Lack of Sterility Assurance
Which agency issued this recall?
This recall was issued by the FDA Drug on August 9, 2017. Severity: Moderate. Recall number: D-1048-2017.